Opioid dose and drug-related mortality in patients with nonmalignant pain
…, MM Mamdani, IA Dhalla, JM Paterson… - Archives of internal …, 2011 - jamanetwork.com
Background Opioids are widely prescribed for chronic nonmalignant pain, often at doses
exceeding those recommended in clinical practice guidelines. However, the risk-benefit ratio of …
exceeding those recommended in clinical practice guidelines. However, the risk-benefit ratio of …
Association between wait time and 30-day mortality in adults undergoing hip fracture surgery
…, B Ravi, D Wasserstein, A Huang, JM Paterson… - Jama, 2017 - jamanetwork.com
Importance Although wait times for hip fracture surgery have been linked to mortality and are
being used as quality-of-care indicators worldwide, controversy exists about the duration of …
being used as quality-of-care indicators worldwide, controversy exists about the duration of …
The burden of opioid-related mortality in the United States
…, M Tadrous, MM Mamdani, JM Paterson… - JAMA network …, 2018 - jamanetwork.com
Importance Opioid prescribing and overdose are leading public health problems in North
America, yet the precise public health burden has not been quantified. Objective To examine …
America, yet the precise public health burden has not been quantified. Objective To examine …
Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case–control study
…, T Antoniou, MM Mamdani, JM Paterson… - PLoS …, 2017 - journals.plos.org
Background Prescription opioid use is highly associated with risk of opioid-related death,
with 1 of every 550 chronic opioid users dying within approximately 2.5 years of their first …
with 1 of every 550 chronic opioid users dying within approximately 2.5 years of their first …
Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study
NN Haroon, JM Paterson, P Li, RD Inman… - Annals of internal …, 2015 - acpjournals.org
Background: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis affecting the spine
in young adults. It is associated with excess cardiovascular and cerebrovascular morbidity. …
in young adults. It is associated with excess cardiovascular and cerebrovascular morbidity. …
[PDF][PDF] Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
CR Dormuth, BR Hemmelgarn, JM Paterson… - Bmj, 2013 - bmj.com
Objective To quantify an association between acute kidney injury and use of high potency
statins versus low potency statins. Design Retrospective observational analysis of …
statins versus low potency statins. Design Retrospective observational analysis of …
Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study
…, R Croxford, D Wasserstein, B Escott, JM Paterson… - Bmj, 2014 - bmj.com
Objectives To identify a cut point in annual surgeon volume associated with increased risk of
complications after primary elective total hip arthroplasty and to quantify any risk identified. …
complications after primary elective total hip arthroplasty and to quantify any risk identified. …
Risk of total knee arthroplasty after operatively treated tibial plateau fracture: a matched-population-based cohort study
D Wasserstein, P Henry, JM Paterson, HJ Kreder… - JBJS, 2014 - journals.lww.com
Background: The aims of operative treatment of displaced tibial plateau fractures are to
stabilize the injured knee to restore optimal function and to minimize the risk of posttraumatic …
stabilize the injured knee to restore optimal function and to minimize the risk of posttraumatic …
[HTML][HTML] A multicenter observational study of incretin-based drugs and heart failure
…, KK Clemens, N Hu, JM Paterson… - … England Journal of …, 2016 - Mass Medical Soc
Background There is concern that antidiabetic incretin-based drugs, including dipeptidyl
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)
J Kaczorowski, LW Chambers, L Dolovich, JM Paterson… - Bmj, 2011 - bmj.com
Objective To evaluate the effectiveness of the community based Cardiovascular Health
Awareness Program (CHAP) on morbidity from cardiovascular disease. Design Community …
Awareness Program (CHAP) on morbidity from cardiovascular disease. Design Community …